These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Medicines Act 1968--its impact on the hospital pharmacist in relation to sterile products. Sprake JM Hosp Eng; 1978 Oct; 32(8):24-7. PubMed ID: 10239209 [No Abstract] [Full Text] [Related]
8. Studies on microbiological contamination of in-use IV-fluids. Stjernström G; Gunnarsson B; Wikner H Acta Pharm Suec; 1978; 15(3):169-74. PubMed ID: 362822 [No Abstract] [Full Text] [Related]
9. Letter: Addition of drugs to intravenous fluids. Lancet; 1976 Apr; 1(7964):858. PubMed ID: 56671 [No Abstract] [Full Text] [Related]
10. [Effect of the Reorganization of Drug Legislation "Act" on the production and admission of infusion solutions]. Mohrbutter K; Schnieders B; Schuster J; Wolff U Klin Anasthesiol Intensivther; 1977; (14):74-88. PubMed ID: 926693 [No Abstract] [Full Text] [Related]
11. [Summary of the discussion on the subject of: "technical problems in the production and use of infusion solutions"]. Klin Anasthesiol Intensivther; 1977; (14):95-105. PubMed ID: 926695 [No Abstract] [Full Text] [Related]
12. Steam sterilization of L.Y.P.'s: an integrated approach to sterilization assurance. Mascoli CC J Pharm Belg; 1977; 32(5):516-9. PubMed ID: 609038 [No Abstract] [Full Text] [Related]
13. Intravenous infusion bottle plugs as a source of microbial contamination. Holmes CJ; Allwood MC J Hyg (Lond); 1976 Dec; 77(3):315-20. PubMed ID: 826586 [TBL] [Abstract][Full Text] [Related]
14. Regulatory issues of parenteral equipment and systems. Avallone H J Parenter Sci Technol; 1988; 42(3):89-93. PubMed ID: 3216268 [No Abstract] [Full Text] [Related]
15. Current good manufacturing practice: proposed revision of certain requirements for finished pharmaceuticals; proposed rule, May 3, 1996 (61 FR 20103), [Docket No. 95N-0362]. Parenteral Drug Association. PDA J Pharm Sci Technol; 1996; 50(6):346-51. PubMed ID: 9038078 [No Abstract] [Full Text] [Related]
16. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies]. Pawlaczyk J; Nowacka D; Wawrzyńczak D Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545 [No Abstract] [Full Text] [Related]
17. [The contamination of large volume parenteral solutions by foreign particles. Proposal for updating the Italian regulations]. Pavanetto F; Montanari L; Conti B; Ponci R Farmaco Prat; 1986 Jan; 41(1):3-14. PubMed ID: 3956714 [No Abstract] [Full Text] [Related]
18. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
20. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization]. Pawlaczyk J; Nowacka D Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998 [No Abstract] [Full Text] [Related] [Next] [New Search]